sábado, 29 de agosto de 2020

Cystic Fibrosis News Today Daily Digest

 

Cystic Fibrosis Weekly Update


Contents:

Transplant Anniversaries Acknowledge Trauma and Triumph

Aug 28, 2020 09:00 am | Lara Govendo



Transplant anniversaries are hard for me. And they’re wonderful. They’re sad, then great again. Up, down, and all around seems to be the cycle of my emotions. These anniversaries affect my body, too. It’s as if I’m reliving the days leading up to my transplant all over again. I turned three years old on Aug. […]
The post Transplant Anniversaries Acknowledge Trauma and Triumph appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Transplant Anniversaries Acknowledge Trauma and Triumph on Facebook

Trikafta’s Arrival in Canada Could Cut CF Deaths by 15% Over 10 Years, Study Suggests

Aug 28, 2020 07:00 am | Joana Carvalho, PhD



Trikafta and Canada forecastIf Trikafta — Vertex Pharmaceuticals’ next-generation triple combination cystic fibrosis (CF) therapy — were to be available in Canada next year, the median age of CF patients could rise by 9.2 years and the number of deaths drop by 15% over the next 1o years, a forecast study reported. However, if arrival of this elexacaftor, tezacaftor, and […]
The post Trikafta’s Arrival in Canada Could Cut CF Deaths by 15% Over 10 Years, Study Suggests appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Trikafta’s Arrival in Canada Could Cut CF Deaths by 15% Over 10 Years, Study Suggests on Facebook

Proteostasis Therapeutics Merges With Yumanity Therapeutics

Aug 27, 2020 07:00 am | Joana Carvalho, PhD



Yumanity TherapeuticsProteostasis Therapeutics (PTI) has entered into a definitive merger agreement with Yumanity Therapeutics to leverage their common expertise about protein misfolding to advance the development of disease-modifying therapies for several disorders. The merger should be complete before the end of the year. The combined company will operate under the name Yumanity Therapeutics, Inc. PTI, which is developing […]
The post Proteostasis Therapeutics Merges With Yumanity Therapeutics appeared first on Cystic Fibrosis News Today.
Read More
share on TwitterLike Proteostasis Therapeutics Merges With Yumanity Therapeutics on Facebook

Recent News

CF Foundation Awards Nearly $15 Million to Groups Researching Infections and CF
A New Way to Hurt: Are You ‘Healthist’?
Xperiome Platform Aims to Streamline Searches for Rare Diseases, Gain Patient Input
Muscles of CF Youth Consume Oxygen Faster Than Peers, Affecting Exercise
Vertex Triple Combo, Kaftrio, Approved for CF Patients in EU With F508del Mutation

No hay comentarios:

Publicar un comentario